FLUOXETINE EG 20 mg, dispersible tablet scored 28 tablets
Active ingredients: Fluoxetine hydrochloride, Fluoxetine
Commercialized according to BDPMANSM noticeDispensing in France: Prescription only
Dispersible tablet scored28 tabletsorale
Supply disruption
Package details
Original BDPM fields are shown in French.
- Official name
- FLUOXETINE EG 20 mg, comprimé dispersible sécable
- Pharmaceutical form
- comprimé dispersible sécable
- Route of administration
- orale
- Presentation description
- plaquette(s) thermoformée(s) PVC polyéthylène PVDC aluminium de 28 comprimé(s)
- Marketing authorisation holder
- EG LABO - LABORATOIRES EUROGENERICS
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 21 Jul 2008
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
66375339CIP73838494CIP133400938384949Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| CHLORHYDRATE DE FLUOXÉTINEcomprimé | — | SA |
| FLUOXÉTINE BASEcomprimé | 20,00 mg · un comprimé | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.